Clinical Trials Directory

Trials / Terminated

TerminatedNCT03020121

Validation of BD Onclarity™ HPV Assay With PreservCyt® -ASCUS Samples

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
28 (actual)
Sponsor
Becton, Dickinson and Company · Industry
Sex
Female
Age
21 Years
Healthy volunteers
Accepted

Summary

The purpose of the study is to compare the results of the Becton Dickinson (BD) Human Papilloma Virus (HPV) Assay on the Viper LT instrument from Liquid-based cytology media diluted in HPV diluent to adjudicated histology results from biopsy.

Conditions

Interventions

TypeNameDescription
PROCEDUREColposcopy/biopsyColposcopy/biopsy will be performed on all subjects

Timeline

Start date
2016-11-01
Primary completion
2017-05-01
Completion
2017-05-01
First posted
2017-01-13
Last updated
2018-01-31

Locations

12 sites across 2 countries: United States, Canada

Source: ClinicalTrials.gov record NCT03020121. Inclusion in this directory is not an endorsement.